Yoshiko Umeyama Selected Research

Yoshiko Umeyama Research Topics

9	Breast Neoplasms (Breast Cancer) 03/2021 - 06/2016
7	Neoplasms (Cancer) 06/2021 - 04/2010
7	Renal Cell Carcinoma (Grawitz Tumor) 03/2020 - 11/2011
6	Neutropenia 01/2021 - 06/2016
3	Fatigue 05/2015 - 04/2010
2	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 05/2018
1	Carcinoma (Carcinomatosis) 02/2022
1	Rectal Neoplasms (Rectal Cancer) 06/2016
1	Esophageal Neoplasms (Esophageal Cancer) 06/2016
1	Anorexia 05/2015
1	Hypertension (High Blood Pressure) 05/2015
1	Nausea 05/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2015
1	Dysphonia (Spastic Dysphonia) 05/2015
1	Hypothyroidism 06/2012
1	Proteinuria 11/2011

12	Axitinib (AG 013736)IBA 06/2021 - 04/2010
9	palbociclibIBA 03/2021 - 06/2016
8	ErbB Receptors (EGF Receptor)IBA 03/2021 - 06/2016
6	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2021 - 04/2010
5	Hormones (Hormone)IBA 03/2021 - 01/2019
4	Estrogen ReceptorsIBA 01/2020 - 06/2016
4	Letrozole (Femara)FDA LinkGeneric 01/2020 - 06/2016
4	Biomarkers (Surrogate Marker)IBA 05/2018 - 04/2010
3	avelumabIBA 02/2022 - 03/2020
3	Cyclin-Dependent Kinase 4IBA 01/2021 - 06/2016
2	Tyrosine Kinase InhibitorsIBA 06/2021 - 04/2015
2	Sorafenib (BAY 43-9006)FDA Link 05/2018 - 04/2015
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2014 - 11/2011
2	CytokinesIBA 12/2014 - 11/2011
1	PlatinumIBA 02/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2021
1	Immunoglobulin G (IgG)IBA 06/2021
1	Angiogenesis InhibitorsIBA 06/2021
1	Immune Checkpoint InhibitorsIBA 06/2021
1	Sunitinib (Sutent)FDA Link 03/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	Fulvestrant (Faslodex)FDA Link 03/2019
1	Gemcitabine FDA Link 05/2015
1	Thyroid HormonesIBA 06/2012
1	Proteins (Proteins, Gene)FDA Link 11/2011
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2010